AU2022902097A0 - Treatment for joint disorders - Google Patents

Treatment for joint disorders

Info

Publication number
AU2022902097A0
AU2022902097A0 AU2022902097A AU2022902097A AU2022902097A0 AU 2022902097 A0 AU2022902097 A0 AU 2022902097A0 AU 2022902097 A AU2022902097 A AU 2022902097A AU 2022902097 A AU2022902097 A AU 2022902097A AU 2022902097 A0 AU2022902097 A0 AU 2022902097A0
Authority
AU
Australia
Prior art keywords
treatment
joint disorders
disorders
joint
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2022902097A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Macquarie University
Original Assignee
Macquarie University
Filing date
Publication date
Application filed by Macquarie University filed Critical Macquarie University
Publication of AU2022902097A0 publication Critical patent/AU2022902097A0/en
Priority to PCT/AU2023/050693 priority Critical patent/WO2024020641A1/en
Abandoned legal-status Critical Current

Links

AU2022902097A 2022-07-27 2022-07-27 Treatment for joint disorders Abandoned AU2022902097A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/AU2023/050693 WO2024020641A1 (en) 2022-07-27 2023-07-27 Vascular endothelial growth factor inhibitors for the treatment of joint disorders

Publications (1)

Publication Number Publication Date
AU2022902097A0 true AU2022902097A0 (en) 2022-08-11

Family

ID=

Similar Documents

Publication Publication Date Title
EP3955937A4 (en) Compounds and methods for the treatment of ocular disorders
EP4149452A4 (en) Combination treatment of liver disorders
EP3977199A4 (en) Electrically-tunable vision aid for treatment of myopia
EP3955926A4 (en) Compounds and methods for the treatment of ocular disorders
EP3934646A4 (en) Pharmaceutical compositions for treating ocular diseases or disorders
EP4076422A4 (en) Methods for improving neurological diseases and disorders
EP4149453A4 (en) Combination treatment of liver disorders
EP4010075A4 (en) Methods for the treatment of apoc3-related diseases and disorders
EP3979996A4 (en) Methods and formulations for treating vision disorders
AU2022902097A0 (en) Treatment for joint disorders
AU2021903303A0 (en) Treatment for joint disorders
AU2022298746A1 (en) Beta-lactam derivatives for the treatment of diseases
EP4096783A4 (en) Compositions for hemorrhoid treatment
EP4040991A4 (en) Treatment for gastrointestinal disorders
EP4161527A4 (en) Compounds and methods for the treatment of eye disorders
EP4021480A4 (en) Peptides for the treatment of renal disorders
EP4045084A4 (en) Compositions and methods for treating blood disorders
EP3990457A4 (en) Compounds for treatment of eye disorders
EP4175944A4 (en) Peptides for treatment of medical disorders
AU2020904573A0 (en) Combination therapy for inflammatory disorders of the joints
AU2021903373A0 (en) Methods for treating disorders
EP4098263A4 (en) Treatment for chondrodystrophia
AU2023902197A0 (en) Treatment for tinnitus
AU2022900634A0 (en) Treatment for neurological conditions
AU2022901482A0 (en) Combination treatment